0001209191-21-040741.txt : 20210615
0001209191-21-040741.hdr.sgml : 20210615
20210615190652
ACCESSION NUMBER: 0001209191-21-040741
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210611
FILED AS OF DATE: 20210615
DATE AS OF CHANGE: 20210615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EHRLICH JASON
CENTRAL INDEX KEY: 0001754049
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38682
FILM NUMBER: 211020093
MAIL ADDRESS:
STREET 1: 2631 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kodiak Sciences Inc.
CENTRAL INDEX KEY: 0001468748
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 270476525
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 PAGE MILL RD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: 650-281-0850
MAIL ADDRESS:
STREET 1: 1200 PAGE MILL RD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
FORMER COMPANY:
FORMER CONFORMED NAME: Oligasis, LLC
DATE OF NAME CHANGE: 20090721
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-11
0
0001468748
Kodiak Sciences Inc.
KOD
0001754049
EHRLICH JASON
1200 PAGE MILL ROAD
PALO ALTO
CA
94304
0
1
0
0
See Remarks
Common Stock
2021-06-11
4
M
0
2900
A
66115
D
Common Stock
2021-06-15
4
S
0
1147
84.75
D
64968
D
Stock Option (Right to Buy)
73.51
2021-06-11
4
A
0
18450
0.00
A
2029-12-29
Common Stock
18450
18450
D
Restricted Stock Units
2021-06-11
4
A
0
11600
0.00
A
Common Stock
11600
11600
D
Restricted Stock Units
2021-06-11
4
M
0
2900
0.00
D
Common Stock
2900
8700
D
Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.
Includes 54 shares acquired under the 2018 Employee Stock Purchase Plan on May 31, 2021.
The sale was made to cover tax withholding obligations in connection with vesting and settlement of 1/4th of the Reporting Person's performance-based RSU granted on December 30, 2019.
On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.
Chief Medical Officer and Chief Development Officer
/s/ David Peinsipp, Attorney-in-Fact for Jason Ehrlich
2021-06-15